Azenta (NASDAQ:AZTA) Upgraded to “Hold” by Zacks Investment Research

Zacks Investment Research upgraded shares of Azenta (NASDAQ:AZTAGet Rating) from a sell rating to a hold rating in a research note released on Tuesday morning, reports.

According to Zacks, “Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass. “

Other analysts have also issued research reports about the stock. B. Riley initiated coverage on shares of Azenta in a research report on Thursday, March 31st. They issued a buy rating on the stock. Needham & Company LLC cut their target price on shares of Azenta from $155.00 to $115.00 and set a buy rating on the stock in a research report on Wednesday, February 9th. Finally, Evercore ISI initiated coverage on shares of Azenta in a research report on Monday, March 21st. They issued an outperform rating and a $100.00 target price on the stock.

Azenta stock opened at $76.16 on Tuesday. The company has a market cap of $5.71 billion, a PE ratio of 44.28 and a beta of 1.65. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.13 and a current ratio of 2.33. Azenta has a twelve month low of $71.19 and a twelve month high of $124.79. The firm has a 50-day moving average of $81.74.

Azenta (NASDAQ:AZTAGet Rating) last announced its earnings results on Tuesday, February 8th. The company reported $0.12 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.08 by $0.04. Azenta had a net margin of 14.57% and a return on equity of 8.87%. The company had revenue of $139.65 million for the quarter, compared to analysts’ expectations of $135.34 million. During the same period last year, the firm earned $0.47 earnings per share. The business’s revenue for the quarter was up 18.2% on a year-over-year basis. As a group, equities analysts forecast that Azenta will post 0.64 EPS for the current year.

Azenta Company Profile (Get Rating)

Azenta, Inc provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide. The company operates in two segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated ultra-cold storage systems and consumables, including racks, tubes, caps, plates, and foils; instruments, such as labeling, bar coding, capping, de-capping, auditing, sealing, peeling, piercing tubes, and plates.

Recommended Stories

Get a free copy of the Zacks research report on Azenta (AZTA)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with's FREE daily email newsletter.